Dr. Peruzzi is an Assistant Professor of Neurosurgery at the Brigham and Women’s Hospital in Boston and Principal Investigator in the Harvey Cushing Neuro-oncology Laboratories at the Harvard Medical School.
He attended medical school in Rome, Italy, and received his neurosurgery training at the Ohio State University, where he also obtained a PhD in molecular biology.
Dr Peruzzi is primarily focused on the care of patients with brain tumors. He is involved in multiple trials investigating the use of oncolytic viruses for the treatment of gliomas and he is also the principal investigator for a Phase 1 clinical trial studying the use of drug-releasing microdevices for in situ, patient-specific characterization of tumor sensitivity to different chemotherapics.
Dr Peruzzi runs a basic science laboratory investigating the role of non-coding RNAs in malignant brain tumors, with a particular interest in exploiting their biological properties to modulate the tumor epigenetic landscape and adaptive response to therapy. For his work, he has received a K12 and K08 Career Development Award from NIH in 2016 and 2017, respectively. He has also been awarded the Neurosurgery Research and Education Foundation Award in 2011 and the American Academy of Neurological Surgery Award in 2018.
